GENERAL ELECTRIC, Danaher and Agilent Technologies, Inc. are Dominating the Global Cell Based Assays Market in 2018

Global Cell-Based Assays Market is expected to grow at a substantial CAGR of 8.7% in the forecast period 2019 to 2026. The years considered for study are as mentioned below:

Access Full Report at https://www.databridgemarketresearch.com/reports/global-cell-based-assays-market

The global cell based assays market is a fragmented market which includes key players and local players. The market is growing owing to the favourable market scenario. The market has a prominent growth in upcoming years due to rising demands for novel small molecules, bio-therapeutic and cell based therapies, increasing incidence of chronic diseases and increase in research and development expenditure.

The market has witnessed developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand. For instance, In July 2019, Agilent Technologies Inc. declared that it will acquire BioTek Instruments for USD 1,165.00 million. BioTek is a worldwide leader in designing, manufacturing and distribution for advanced life science instruments. With the acquisition Agilent's will be able to deliver an extensiveness of differentiated workflows and it will also be able to assist customers to get in depth, more reliable insights for variety of cell analysis.

GENERAL ELECTRIC dominated the global cell based assays market. The other key players in the market are Danaher, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories, Inc., ATCC, Aurelia Bioscience Ltd, BD, BioAgilytix Labs, BioVision Inc., Cell Signaling Technology, Inc, Cisbio, Enzo Biochem Inc., Eurofins Scientific, LakePharma, Inc., Lonza, Miltenyi Biotec, XenoDiagnostics, LLC and others.

GENERAL ELECTRIC:

GENERAL ELECTRIC is headquartered in Massachusetts, U.S. was incorporated in 1892. The company focused on the development and manufacture building purposes, lighting, power systems and other products that provide support homes, offices, factories and retail facilities. The company’s business segment includes power, renewable energy, aviation, oil & gas, healthcare, transportation, lightings and capital in which healthcare is market focused segment.

The company’s product categories includes GE Additive, GE Aviation, GE Capital, GE Digital, GE Healthcare, GE Lighting, GE Power, GE Renewable Energy, GE Research in which GE Healthcare is market focused category. The company has approx. 283,000 employees as of December 2018.

  • In November 2018, GE Healthcare Life Sciences announced to open new biotechnology manufacturing center for improving capability of biopharmaceuticals, gene therapies and viral vectors. By this manufacturing center company expand business.

It has its global networks through direct sales representatives and distributors in Europe, America, Asia-Pacific, Middle East and Africa. The company has various subsidiaries such as GE Capital or Financial Services (U.S.), GE Healthcare (U.S.), General Electric Capital Corporation or GECC (U.S.), GE Industrial (U.S.), GE Capital Global Holdings, LLC (U.S.), Baker Hughes (U.S.) and others.

Danaher:

Danaher headquartered in Pennsylvania, U.S. was founded in 1969. The company is engaged in providing innovative product and high standard technologies to solve customers’ most complex challenges.  The company’s business segment includes life science, diagnostics, dental, environmental & applied solutions in which life science is market focused segment. The company’s product categories include Diagnostics, Life Sciences, Dental, Environmental & Applied Solutions in which Life Sciences is market focused category. The company has Approx. 71,000 employees as of 2018.

It has its global networks through direct sales representatives and distributors in North America, South America, APAC, Europe, Middle East and Africa. The company has various subsidiaries such as Ormco Corporation (U.S.), Nobel Biocare Services AG (Switzerland), Implant Direct (U.S.), KaVo Kerr (U.S.), ALLTEC/FOBA (Germany) among others.

Agilent Technologies, Inc

Agilent Technologies, Inc., headquartered in California, U.S. was founded in 1999. The company is engaged in providing worldwide laboratories with instruments, consumables, services, applications which helps the customers. The company is providing analytical instruments & supplies, life science, clinical & diagnostic testing, lab management & consulting, lab software, dissolution testing, lab automation, vacuum & leak detection, academia, cell metabolism, pharma & biopharma, clinical diagnostics, clinical research, energy & chemicals, environmental, food testing & agriculture, forensics, genomics, geochemistry, mining & metals, homeland security, materials testing & research, metabolomics, pathology, proteomics, semiconductor analysis, specialty chemicals, vacuum solutions. The market focus products lie under life science category. The company deals into Life sciences and applied markets, Diagnostics and Others business categories. The market focus business segment is Life sciences and applied markets. The company has approx. Approx. 14,800 employees.

In July 2019, Agilent Technologies Inc. declared that it will acquire BioTek Instruments for USD 1,165.00 million. BioTek is a worldwide leader in designing, manufacturing and distribution for advanced life science instruments. With the acquisition Agilent's will be able to deliver an extensiveness of differentiated workflows and it will also be able to assist customers to get in depth, more reliable insights for variety of cell analysis.

It has its global networks through direct sales representatives and distributors in Europe, Middle East, Africa, Americas, Asia-Pacific. The company has various subsidiaries such as BioTek Instruments, Inc. (U.S.), ACEA Biosciences, Inc (U.S), Advanced Analytical Technologies, Inc. (U.S.), ProZyme, Inc. (U.S.), LaserGen, Inc. (U.S.) among others.